REFERÊNCIAS
1. Baltazard M, Bahmanyer M, Ghodssi M, et al: Essai pratique du sérum antirabique
les mordus par loups enragés. Bull WHO 13:747-72. 1995.
2. Habel K, Korowski H: Laboratory data supporting the clinical trial of antirabies
serum in persons bitten by a rabid wolf. Bull WHO 13:773-9, 1966.
3. Selimov M, BoltucilJ L., Semenova E. et al: [The use of antirabies gamma globulin
in subjects severely bitten by rabid wolves or other animals]. Hyg Epidemiol
Microbiol Immunol (Praha) 3:168-80, 1959.
4. Atanasiu P, Bahmanyer M, Baltazard M. et al: Rabies neutralizing antibody
response to different schedules of serum and vaccine innoculations in non-exposed
persons. Bull. WHO 14:593-611. 1956.
5. Atanasiu P. Bahmanyar M, Baltazard M. et al: Rabies neutralizing antibody
response to different schedules of serum and vaccine innoculations in non-exposed
persons: Part II. Bull WHO 176:911-32. 1957.
6. Atanasiu P. Cannon DA, Dean DJ et al: Rabies neutralizing antibody response to
different schedules of serum and vaccine innoculations in non-exposed persons: Part
3. Bull WHO 25:103-14. 1961.
7. Atanasiu P. Dean DJ, Habel K, et al: Rabies neutralizing antibody response to
different schedules of serum and vaccine inoculations in non-exposed persons: Part
4. Bull WHO 36:361-5. 1967.
8. Cabasso VJ, Loofbourow JC, Roby RE, et al. Rabies immune globulin of human
origin: preparation and dosage determination in non-exposed volunteer subjects.
Bull WHO 45:303-15. 1971.
9. Loofbourow JC, Cabasso VJ, Roby RE et al: Rabies immune globulin (human):
clinical trials and dose determination. JAMA 217(13): 1825-31. 1971.
10. Plotkin SA: New rabies vaccine halts disease – without severe reactions. Mod Med
45(20):45-8, 1977.
11. Plotkin SA, Wiktor TJ, Koprowski H, et al: immunization schedules for the new
human diploid cell vaccine against rabies. Am J Epidemiol 103(1):75-80, 1975.
12. Hafkin B, Hattwick MA, Smith JS, et al: A comparison of a WI-38 vaccinee and
duck embryo vaccine for preexposure rabies prophylaxis. Am J Epidemiol 107(5):
439-43, 1978.
13. Kwert EK, Marcus I, Höher PG: Neutralizing and complement-fixing antibbody
responses in pre- and post-exposure vaccineees to a rabies vaccine produced in
human diploid cells. J Biol Stand 4(4):249-62. 1976.
14. Grandien M: Evaluation of testes for rabies antibody and analysis of serum
responses after administration of three different types of rabies vaccines. J Clin
Microbiol 5(3):163-7. 1977
15. Kwert EK, Marcus I, Werner J. et al: Postexpositionelle Schutzimpfung des
Menschen gegen Tollwut mit einer neu-entwckelten Gewebekulturvakzine (HDCS-
impfstoff). Zentraibl Bakteriol (A) 239(4):437-58. 1977.
16. Bahmanyar M, Fayaz A, Nour-Salehi S. et al: Successful protection of humans
exposed to rabies infection: postexposure treatment with the new human diploid cell
rabies vaccine and antirabies serum. JAMA 236(24):2751-4. 1976.
17. Americam Hospital Formulary Service. Drug information. Section 80:04. Rabies
immune globulin. Bethesda, American Society for Health-Systems Pharmacy, 1997,
p. 2545-7.
18. Rubin Rh, Sikes RK, Gregg MB: Human rabies immune globulin. Clinical Trials
and Effects on serum anti-globulins. JAMA 224:871-4, 1973.